QRFPR
| Official symbol: | QRFPR |
| Full name: | pyroglutamylated RFamide peptide receptor |
| Location: | 4q27 |
| Also known as: | GPR103 |
| Entrez ID: | 84109 |
| Ensembl ID: | ENSG00000186867 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Expression restricted in 2 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 0 |
|
|
|
| |
|
|
|
| Functional class: | G protein-coupled receptor |
| JensenLab PubMed score: | 25.69 (Percentile rank: 51.54%) |
| PubTator score: | 13.76 (Percentile rank: 45.57%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |
